The second-year tracking shift

The tracker abandonment in year two is understandable and almost universal, because the original use case — making sense of a new and changing experience — no longer applies. Everything has settled. Tracking feels like documenting the absence of events.

What most people don't realise until they're sitting in a prescription review with eight months of unrecorded history is that the year-two log isn't for the same thing as the year-one log. It's not for making sense of change. It's for maintaining a continuous record that covers the quiet period between reviews — the months where nothing dramatic happened but where a complete archive is genuinely useful to anyone who needs to understand your full journey.

A two-year record is qualitatively different from a one-year record. It covers the period past the first-year dropout that most clinical data stops tracking. It contains the context for any new observation: you can say 'I noticed this in month 19, it wasn't present at month 12, here's the 7-month context' rather than 'I'm not sure when it started.' The year-two log doesn't need to be as detailed as year one.

It covers the period past the first-year dropout that most clinical data stops tracking.

Three fields, once a week, under five minutes — that's the maintenance mode that keeps the record continuous without requiring the same level of active engagement as the change-heavy first year. Titra doesn't ask you to log differently as your journey evolves — the same structure that works in month 3 works in month 18, just used less urgently. The point is that you don't have to start over.

The record you built in year one carries forward. Year two is just keeping it alive.